2011 - 10th Meeting - IHCTAS


This page contains exclusive content for the member of the following sections: TTS, IHCTAS. Log in to view.

Posters

2.29 - VASCULARIZED BONE MARROW TRANSPLANTATION: AN ALTERNATIVE TO CONVENTIONAL CELLULAR BONE MARROW TRANSPLANTATION

Presenter: Dragos, Zamfirescu, Bucharest, Romania
Authors: Dragos Zamfirescu, Ioan Lascar, Ion Zegrea, Marius Popescu, Corina Popoviciu, Mihail Climov, Marco Lanzetta

VASCULARIZED BONE MARROW TRANSPLANTATION: AN ALTERNATIVE TO CONVENTIONAL CELLULAR BONE MARROW TRANSPLANTATION

Dragos Zamfirescu1, Ioan Lascar1, Ion Zegrea1, Marius Popescu1, Corina Popoviciu1, Mihail Climov2, Marco Lanzetta3,4.

1Plastic Surgery and Reconstructive Microsurgery Clinic, “Carol Davila” Bucharest Medical University, Bucharest, Romania; 2Harvard Medical School; 3Italian Institute for Hand Surgery and Microsurgery, Monza, Milan, Italy; 4University of Canberra, Australia.

Background: Current protocols for bone marrow transplantation (BMT) involve removing the bone marrow component directly from its donor microenvironment and then injecting such components into the circulatory system of the recipient. This procedure is usually preceded by conditioning protocols (body irradiation, immunosuppression, or both). Vascularized bone marrow transplantation (VBMT), in comparison with conventional marrow transplants, has the advantage of providing a microenvironment and immediate engraftment of both mature and progenitor hemopoietic cells at the time of transplantation in the absence of immunomodulation or irradiation. The aim of the study was to follow the development of microchimerism after allogeneic VBMT vs conventional BMT.

Methods: In one group a VBMT model consisted of a donor Brown Norway (BN) rat hind limb heterotopic transplanted on recipient Lewis rats was used. An intravenous infusion of donor bone marrow cells in suspension equivalent to that grafted in the vascularized femur limb was administrated i.v. on recipient rats in the second group. Cellular microchimerism was investigated in recipients of VBMT vs BMT.

Results: Donor-derived cells could be detected in VBMT recipients at 30 and 60 days but not in recipients of i.v. suspension BMC grafting.

Conclusions: VBMT provides a theoretical alternative to conventional cellular bone marrow transplantation by addressing crucial clinical problems such as failure of engraftment or graft versus host disease. It may be possible to develop a new approach for bone marrow transplantation based primarily on a microsurgical procedure (transplantation of vascularized bone marrow flaps).


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada